5323002026-07-175323002026-07-172026-07-17RelatedPartyTransactionDomain15323002026-07-172026-07-17RelatedPartyTransactionDomain25323002026-07-172026-07-17RelatedPartyTransactionDomain35323002026-07-172026-07-17RelatedPartyTransactionDomain45323002026-07-172026-07-17RelatedPartyTransactionDomain55323002026-07-172026-07-17ResolutionOrAgendaDomain15323002026-07-17ResolutionOrAgendaDomain15323002026-07-172026-07-17ResolutionOrAgendaDomain25323002026-07-17ResolutionOrAgendaDomain25323002026-07-172026-07-17ResolutionOrAgendaDomain35323002026-07-17ResolutionOrAgendaDomain35323002026-07-172026-07-17ResolutionOrAgendaDomain45323002026-07-17ResolutionOrAgendaDomain45323002026-07-172026-07-17ResolutionOrAgendaDomain55323002026-07-17ResolutionOrAgendaDomain55323002026-07-172026-07-17ResolutionOrAgendaDomain65323002026-07-17ResolutionOrAgendaDomain65323002026-07-172026-07-17ResolutionOrAgendaDomain75323002026-07-17ResolutionOrAgendaDomain75323002026-07-172026-07-17ResolutionOrAgendaDomain85323002026-07-17ResolutionOrAgendaDomain85323002026-07-172026-07-17ResolutionOrAgendaDomain95323002026-07-17ResolutionOrAgendaDomain95323002026-07-172026-07-17ResolutionOrAgendaDomain105323002026-07-17ResolutionOrAgendaDomain10iso4217:INRxbrli:pureWockhardt LimitedWOCKPHARMANew2026-08-1015:30:002026-07-17Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)1Monday2026-08-1015:30:00Chhatrapati Sambhajinagar10Wockhardt LimitedWockhardt Bio AGSubsidiary of Wockhardt LimitedSale of goods or services65000000002026-08-102027-09-30Omnibus approval sought for ongoing transactionsWockhardt LimitedWockhardt Bio AGSubsidiary of Wockhardt LimitedSale of goods or services1000000002026-08-102027-09-30Omnibus approval sought for ongoing transactionsWockhardt LimitedWockhardt Bio AGSubsidiary of Wockhardt LimitedAny other transactionTransfer of Intellectual Property Rights/ distribution rights for various regions or other investments34000000002026-08-102027-09-30Omnibus approval sought for ongoing transactionsWockhardt Bio AGCP Pharmaceuticals LimitedWholly Owned Subsidiary of Wockhardt Bio AGPurchase of goods or services55000000002026-08-102027-09-30Omnibus approval sought for ongoing transactionsWockhardt Bio AGWockhardt UK LimitedWholly Owned Subsidiary of Wockhardt Bio AGSale of goods or services55000000002026-08-102027-09-30Omnibus approval sought for ongoing transactionsOrdinary ResolutionAdoption of Financial StatementsAdoption of: a. the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon; and b. the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026 together with the Report of the Auditors thereonOrdinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRetirement by rotationAppointment of Director in place of Ms. Zahabiya Khorakiwala (DIN: 00102689), who retires from office by rotation and, being eligible, offers herself for re-appointment.Non-Executive - Non-Independent DirectorMs. Zahabiya Khorakiwala001026892023-08-142026-08-10Ordinary ResolutionOthersOthersRatification of remuneration payable to the Cost Auditors for the Financial Year 2026-27To ratify remuneration payable to Kirit Mehta & Co. LLP, Cost Accountants (Firm Registration No. 000353), as the Cost Auditors for conducting the Cost Audit of the Company for the financial year ending on March 31, 2027.Special ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRemunerationRevision of the remuneration payable to Dr. Habil Khorakiwala (DIN: 00045608), Executive ChairmanExecutive DirectorDr. Habil Khorakiwala000456082025-03-012030-02-28150000000Ordinary ResolutionRelated Party TransactionApproval of Material Related Party Transactions with Wockhardt Bio AG, a subsidiary of the CompanyOrdinary ResolutionRelated Party TransactionApproval of Material Related Party Transactions among Wockhardt Bio AG and CP Pharmaceuticals Limited, subsidiaries of the CompanyOrdinary ResolutionRelated Party TransactionApproval of Material Related Party Transactions among Wockhardt Bio AG and Wockhardt UK Limited, subsidiaries of the CompanySpecial ResolutionIssuance/Corporate ActionIssuance of SecuritiesApproval for raising additional capital by way of one or more public or private offerings including through a Qualified Institutions Placement (“QIP”) to eligible investors through issuance of Equity Shares or other eligible securities for an amount not exceeding ₹ 3,000 CroreOrdinary ResolutionOthersOthersAppointment of Ms. Zahabiya Khorakiwala as an Executive Co-chairperson of Wockhardt Bio AG, a subsidiary of the Company and approval of the remuneration payable to herAppointment of Ms. Zahabiya Khorakiwala as an Executive Co-chairperson of Wockhardt Bio AG, a subsidiary of the Company and approval of the remuneration payable to herSpecial ResolutionOthersOthersModification in the Objects of Qualified Institutions PlacementApproval for the redeployment of the Net Proceeds of the Qualified Institutions Placement dated November 11, 2024, that are yet to be utilised